Research graph
References from Ovarian Precancerous Lesions and Their Molecular Landscape: A Structured Scoping Review Focused on STIC and Related Precursors of Epithelial Ovarian Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Ovarian cancer statistics, 2018
2018 · External reference
Epidemiology of ovarian cancer: A review
10.20892/j.issn.2095-3941.2016.0084 · 2017 · External reference
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 · External reference
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded
10.1016/j.ajpath.2015.11.011 · 2016 · External reference
High grade serous ovarian carcinomas originate in the fallopian tube
10.1038/s41467-017-00962-1 · 2017 · External reference
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
10.1002/path.2091 · 2007 · External reference
Cancer-Associated Mutations in Endometriosis without Cancer
10.1056/nejmoa1614814 · 2017 · External reference
ARID1A mutations in endometriosis-associated ovarian carcinomas
10.1056/nejmoa1008433 · 2010 · External reference
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
10.1093/jnci/95.6.484 · 2003 · External reference
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
10.1016/j.ijsu.2021.105906 · 2021 · External reference
The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory
10.1097/pas.0b013e3181cf3d79 · 2010 · External reference
Incessant ovulation and ovarian cancer—A hypothesis re-visited
2013 · External reference
Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma
10.1016/j.ygyno.2013.12.015 · 2014 · External reference
The distal fallopian tube: A new model for pelvic serous carcinogenesis
10.1097/gco.0b013e328011a21f · 2007 · External reference
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
10.1158/1078-0432.ccr-21-1643 · 2022 · External reference
Endometriosis: Pathogenesis and treatment
10.1038/nrendo.2013.255 · 2014 · External reference
Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer
10.1038/nrc4019 · 2015 · External reference
The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma
10.1016/j.ygyno.2018.11.033 · 2019 · External reference
10.3390/diagnostics7010012
10.3390/diagnostics7010012 · External reference
Serous carcinogenesis in the fallopian tube: A descriptive classification
10.1097/pgp.0b013e31814b191f · 2008 · External reference
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
10.1016/j.ygyno.2008.01.012 · 2008 · External reference
Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube
10.1002/path.2739 · 2010 · External reference
PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer
10.1038/onc.2016.455 · 2017 · External reference
Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: A pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer)
10.1097/pgp.0000000000000123 · 2015 · External reference
LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions
10.1038/modpathol.2017.53 · 2017 · External reference
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions
10.1158/0008-5472.can-25-3189 · 2026 · External reference
Serous tubal intraepithelial carcinoma and the dominant ovarian mass: Clues to serous tumor origin?
10.1097/pas.0b013e3181868904 · 2009 · External reference
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
10.1111/his.12046 · 2013 · External reference
10.3390/diagnostics14222577
10.3390/diagnostics14222577 · External reference
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study
10.1158/1940-6207.capr-18-0009 · 2018 · External reference
Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
10.1200/jco.2007.12.2622 · 2007 · External reference
Inherited Mutations in Women with Ovarian Carcinoma
10.1001/jamaoncol.2015.5495 · 2016 · External reference
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
10.1097/01.pas.0000213335.40358.47 · 2007 · External reference
10.3390/ijms22094409
10.3390/ijms22094409 · External reference
Ovarian cancer pathogenesis: A model in evolution
10.1155/2010/932371 · 2010 · External reference
A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)-Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities
10.1016/j.modpat.2025.100890 · 2025 · External reference
Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions
10.1002/path.5219 · 2019 · External reference
10.3390/cancers13143465
10.3390/cancers13143465 · External reference
The TP53 tumor suppressor gene: From molecular biology to clinical investigations
10.1111/joim.20106 · 2025 · External reference
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions
10.1097/pas.0000000000002187 · 2024 · External reference
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
10.1158/2159-8290.cd-24-1366 · 2025 · External reference
Targeting autophagy in cancer
10.1038/nrc.2017.53 · 2017 · External reference
Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells
10.18632/oncotarget.23747 · 2017 · External reference
The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions
10.1002/path.6322 · 2024 · External reference
Clinical outcomes following identification of an incidental p53 signature in the fallopian tube
10.1016/j.gore.2024.101359 · 2024 · External reference
Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment
10.1155/2018/5416923 · 2018 · External reference
The Origin of Ovarian Cancer Species and Precancerous Landscape
10.1016/j.ajpath.2020.09.006 · 2021 · External reference
10.3390/cancers13030468
10.3390/cancers13030468 · External reference
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
10.3802/jgo.2022.33.e50 · 2022 · External reference
Inherited TP53 Mutations and the Li-Fraumeni Syndrome
10.1101/cshperspect.a026187 · 2017 · External reference
Tumor Dormancy and Slow-Cycling Cancer Cells
10.1007/978-3-030-22254-3_15 · 2019 · External reference
Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma
10.1593/neo.11138 · 2011 · External reference
Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca; Tp53; Pten models
10.1016/j.ccr.2013.10.013 · 2013 · External reference
10.3390/ijms25020886
10.3390/ijms25020886 · External reference
BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis
10.1158/0008-5472.can-20-1830 · 2020 · External reference
BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling
10.1038/s41598-022-08461-0 · 2022 · External reference
10.3390/ijms22031266
10.3390/ijms22031266 · External reference
Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube
10.1038/s41467-025-58145-2 · 2025 · External reference
10.3390/cimb47090702
10.3390/cimb47090702 · External reference
10.1371/journal.pgen.1008558
10.1371/journal.pgen.1008558 · External reference
Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
10.3390/cimb46090555 · 2024 · External reference
The role for autophagy in cancer
10.1172/jci73941 · 2015 · External reference
The Extracellular Matrix of Ovarian Cortical Inclusion Cysts Modulates Invasion of Fallopian Tube Epithelial Cells
10.1063/1.5022595 · 2018 · External reference
Cancer stem cells revisited
10.1038/nm.4409 · 2017 · External reference
Two types of ovarian cortical inclusion cysts: Proposed origin and possible role in ovarian serous carcinogenesis
10.1097/pgp.0000000000000120 · 2015 · External reference
Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy
10.1111/his.13444 · 2018 · External reference
10.1371/journal.pone.0010358
10.1371/journal.pone.0010358 · External reference
Tubal Origin of “Ovarian” Low-Grade Serous Carcinoma: A Gene Expression Profile Study
10.1155/2019/8659754 · 2019 · External reference
Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies
10.1016/s1470-2045(11)70404-1 · 2012 · External reference
10.3390/cancers12061676
10.3390/cancers12061676 · External reference
Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress
10.1158/1078-0432.ccr-07-1614 · 2008 · External reference
Ovarian cancer in endometriosis: Epidemiology, natural history, and clinical diagnosis
10.1007/s10147-009-0931-2 · 2009 · External reference
Endometriosis: A Comprehensive Exploration of Inflammatory Mechanisms and Fertility Implications
2024 · External reference
Association between endometriosis and müllerian anomalies: A retrospective study supporting the retrograde menstruation theory
10.1016/j.fertnstert.2025.07.386 · 2025 · External reference
10.3390/jcm14092975
10.3390/jcm14092975 · External reference
Molecular landscape of borderline ovarian tumours: A systematic review
10.1515/med-2024-0976 · 2024 · External reference
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas
10.2353/ajpath.2010.100212 · 2010 · External reference
The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives
10.2147/cmar.s250394 · 2020 · External reference
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
10.1186/s13053-022-00218-0 · 2022 · External reference
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent
10.1097/01.pas.0000213294.81154.95 · 2006 · External reference
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary
10.1016/j.ygyno.2010.01.006 · 2010 · External reference
Borderline tumors of the ovary: Clinical course and prognostic factors
10.1159/000336140 · 2012 · External reference
Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer
10.1016/j.ygyno.2005.02.022 · 2005 · External reference
Unresolved reference
External reference
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: A nested case-control study
10.1038/sj.bjc.6602199 · 2004 · External reference
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
10.1086/318787 · 2001 · External reference
10.3390/cancers12040956
10.3390/cancers12040956 · External reference
10.3389/fonc.2014.00104
10.3389/fonc.2014.00104 · External reference
Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review
10.1001/jamasurg.2023.4164 · 2023 · External reference
Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast Cancer Resection
10.1001/jamasurg.2023.4770 · 2023 · External reference
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026
10.6004/jnccn.2026.0007 · 2026 · External reference
Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries
10.1002/cncr.32620 · 2020 · External reference
Evaluation of SEE-FIM (Sectioning and Extensively Examining the FIMbriated End) Protocol in Identifying Fallopian Tube Precursor Lesions in Women with Ovarian Tumors
10.1007/s13224-018-1155-z · 2019 · External reference
10.3390/jcm10184235
10.3390/jcm10184235 · External reference
Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study
10.1002/cam4.7132 · 2024 · External reference
Inherited Mutations in Women with Ovarian Carcinoma
10.1001/jamaoncol.2015.5495 · ExternalCitation · doi-reference
Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review
10.1001/jamasurg.2023.4164 · ExternalCitation · doi-reference
Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast Cancer Resection
10.1001/jamasurg.2023.4770 · ExternalCitation · doi-reference
Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study
10.1002/cam4.7132 · ExternalCitation · doi-reference
Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries
10.1002/cncr.32620 · ExternalCitation · doi-reference
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
10.1002/path.2091 · ExternalCitation · doi-reference
Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube
10.1002/path.2739 · ExternalCitation · doi-reference
Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions
10.1002/path.5219 · ExternalCitation · doi-reference
The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions
10.1002/path.6322 · ExternalCitation · doi-reference
Tumor Dormancy and Slow-Cycling Cancer Cells
10.1007/978-3-030-22254-3_15 · ExternalCitation · doi-reference
Ovarian cancer in endometriosis: Epidemiology, natural history, and clinical diagnosis
10.1007/s10147-009-0931-2 · ExternalCitation · doi-reference
Evaluation of SEE-FIM (Sectioning and Extensively Examining the FIMbriated End) Protocol in Identifying Fallopian Tube Precursor Lesions in Women with Ovarian Tumors
10.1007/s13224-018-1155-z · ExternalCitation · doi-reference
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded
10.1016/j.ajpath.2015.11.011 · ExternalCitation · doi-reference
The Origin of Ovarian Cancer Species and Precancerous Landscape
10.1016/j.ajpath.2020.09.006 · ExternalCitation · doi-reference
Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca; Tp53; Pten models
10.1016/j.ccr.2013.10.013 · ExternalCitation · doi-reference
Association between endometriosis and müllerian anomalies: A retrospective study supporting the retrograde menstruation theory
10.1016/j.fertnstert.2025.07.386 · ExternalCitation · doi-reference
Clinical outcomes following identification of an incidental p53 signature in the fallopian tube
10.1016/j.gore.2024.101359 · ExternalCitation · doi-reference
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
10.1016/j.ijsu.2021.105906 · ExternalCitation · doi-reference
A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)-Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities
10.1016/j.modpat.2025.100890 · ExternalCitation · doi-reference
Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer
10.1016/j.ygyno.2005.02.022 · ExternalCitation · doi-reference
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
10.1016/j.ygyno.2008.01.012 · ExternalCitation · doi-reference
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary
10.1016/j.ygyno.2010.01.006 · ExternalCitation · doi-reference
Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma
10.1016/j.ygyno.2013.12.015 · ExternalCitation · doi-reference
The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma
10.1016/j.ygyno.2018.11.033 · ExternalCitation · doi-reference
Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies
10.1016/s1470-2045(11)70404-1 · ExternalCitation · doi-reference
LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions
10.1038/modpathol.2017.53 · ExternalCitation · doi-reference
Cancer stem cells revisited
10.1038/nm.4409 · ExternalCitation · doi-reference
Targeting autophagy in cancer
10.1038/nrc.2017.53 · ExternalCitation · doi-reference
Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer
10.1038/nrc4019 · ExternalCitation · doi-reference
Endometriosis: Pathogenesis and treatment
10.1038/nrendo.2013.255 · ExternalCitation · doi-reference
PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer
10.1038/onc.2016.455 · ExternalCitation · doi-reference
High grade serous ovarian carcinomas originate in the fallopian tube
10.1038/s41467-017-00962-1 · ExternalCitation · doi-reference
Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube
10.1038/s41467-025-58145-2 · ExternalCitation · doi-reference
BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling
10.1038/s41598-022-08461-0 · ExternalCitation · doi-reference
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: A nested case-control study
10.1038/sj.bjc.6602199 · ExternalCitation · doi-reference
ARID1A mutations in endometriosis-associated ovarian carcinomas
10.1056/nejmoa1008433 · ExternalCitation · doi-reference
Cancer-Associated Mutations in Endometriosis without Cancer
10.1056/nejmoa1614814 · ExternalCitation · doi-reference
The Extracellular Matrix of Ovarian Cortical Inclusion Cysts Modulates Invasion of Fallopian Tube Epithelial Cells
10.1063/1.5022595 · ExternalCitation · doi-reference
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
10.1086/318787 · ExternalCitation · doi-reference
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
10.1093/jnci/95.6.484 · ExternalCitation · doi-reference
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent
10.1097/01.pas.0000213294.81154.95 · ExternalCitation · doi-reference
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
10.1097/01.pas.0000213335.40358.47 · ExternalCitation · doi-reference
The distal fallopian tube: A new model for pelvic serous carcinogenesis
10.1097/gco.0b013e328011a21f · ExternalCitation · doi-reference
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions
10.1097/pas.0000000000002187 · ExternalCitation · doi-reference
Serous tubal intraepithelial carcinoma and the dominant ovarian mass: Clues to serous tumor origin?
10.1097/pas.0b013e3181868904 · ExternalCitation · doi-reference
The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory
10.1097/pas.0b013e3181cf3d79 · ExternalCitation · doi-reference
Two types of ovarian cortical inclusion cysts: Proposed origin and possible role in ovarian serous carcinogenesis
10.1097/pgp.0000000000000120 · ExternalCitation · doi-reference
Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: A pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer)
10.1097/pgp.0000000000000123 · ExternalCitation · doi-reference
Serous carcinogenesis in the fallopian tube: A descriptive classification
10.1097/pgp.0b013e31814b191f · ExternalCitation · doi-reference
Inherited TP53 Mutations and the Li-Fraumeni Syndrome
10.1101/cshperspect.a026187 · ExternalCitation · doi-reference
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
10.1111/his.12046 · ExternalCitation · doi-reference
Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy
10.1111/his.13444 · ExternalCitation · doi-reference
The TP53 tumor suppressor gene: From molecular biology to clinical investigations
10.1111/joim.20106 · ExternalCitation · doi-reference
Ovarian cancer pathogenesis: A model in evolution
10.1155/2010/932371 · ExternalCitation · doi-reference
Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment
10.1155/2018/5416923 · ExternalCitation · doi-reference
Tubal Origin of “Ovarian” Low-Grade Serous Carcinoma: A Gene Expression Profile Study
10.1155/2019/8659754 · ExternalCitation · doi-reference
BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis
10.1158/0008-5472.can-20-1830 · ExternalCitation · doi-reference
Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions
10.1158/0008-5472.can-25-3189 · ExternalCitation · doi-reference
Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress
10.1158/1078-0432.ccr-07-1614 · ExternalCitation · doi-reference
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
10.1158/1078-0432.ccr-21-1643 · ExternalCitation · doi-reference
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study
10.1158/1940-6207.capr-18-0009 · ExternalCitation · doi-reference
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
10.1158/2159-8290.cd-24-1366 · ExternalCitation · doi-reference
Borderline tumors of the ovary: Clinical course and prognostic factors
10.1159/000336140 · ExternalCitation · doi-reference
The role for autophagy in cancer
10.1172/jci73941 · ExternalCitation · doi-reference
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
10.1186/s13053-022-00218-0 · ExternalCitation · doi-reference
Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
10.1200/jco.2007.12.2622 · ExternalCitation · doi-reference
10.1371/journal.pgen.1008558
10.1371/journal.pgen.1008558 · ExternalCitation · doi-reference
10.1371/journal.pone.0010358
10.1371/journal.pone.0010358 · ExternalCitation · doi-reference
Molecular landscape of borderline ovarian tumours: A systematic review
10.1515/med-2024-0976 · ExternalCitation · doi-reference
Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma
10.1593/neo.11138 · ExternalCitation · doi-reference
Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells
10.18632/oncotarget.23747 · ExternalCitation · doi-reference
Epidemiology of ovarian cancer: A review
10.20892/j.issn.2095-3941.2016.0084 · ExternalCitation · doi-reference
The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives
10.2147/cmar.s250394 · ExternalCitation · doi-reference
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas
10.2353/ajpath.2010.100212 · ExternalCitation · doi-reference
10.3389/fonc.2014.00104
10.3389/fonc.2014.00104 · ExternalCitation · doi-reference
10.3390/cancers12040956
10.3390/cancers12040956 · ExternalCitation · doi-reference
10.3390/cancers12061676
10.3390/cancers12061676 · ExternalCitation · doi-reference
10.3390/cancers13030468
10.3390/cancers13030468 · ExternalCitation · doi-reference
10.3390/cancers13143465
10.3390/cancers13143465 · ExternalCitation · doi-reference
Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
10.3390/cimb46090555 · ExternalCitation · doi-reference
10.3390/cimb47090702
10.3390/cimb47090702 · ExternalCitation · doi-reference
10.3390/diagnostics14222577
10.3390/diagnostics14222577 · ExternalCitation · doi-reference
10.3390/diagnostics7010012
10.3390/diagnostics7010012 · ExternalCitation · doi-reference
10.3390/ijms22031266
10.3390/ijms22031266 · ExternalCitation · doi-reference
10.3390/ijms22094409
10.3390/ijms22094409 · ExternalCitation · doi-reference
10.3390/ijms25020886
10.3390/ijms25020886 · ExternalCitation · doi-reference
10.3390/jcm10184235
10.3390/jcm10184235 · ExternalCitation · doi-reference
10.3390/jcm14092975
10.3390/jcm14092975 · ExternalCitation · doi-reference
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
10.3802/jgo.2022.33.e50 · ExternalCitation · doi-reference
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026
10.6004/jnccn.2026.0007 · ExternalCitation · doi-reference
